PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: SFL Regulatory Affairs & Scientific Comm.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SFL Selected As Finalist in the 2012 British-Swiss Business Awards - SFL Regulatory Affairs and Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards - SFL-Services.com
SFL Selected As Finalist in the 2012 British-Swiss Business Awards

 

NewswireToday - /newswire/ - Basel, Switzerland, 2012/10/11 - SFL Regulatory Affairs and Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards - SFL-Services.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The British-Swiss Business Awards recognize companies for the outstanding contributions they have made to bilateral trade and investment between the UK and Switzerland.

SFL has been nominated as a finalist in the “Most Promising New Business/Entrepreneur” category, which is awarded to a business or organization, which has been in operation for three years or less, and has demonstrated excellence in research, development, innovation and overall solid business practices. As a company, SFL has grown rapidly from one employee when founded in 2009 in Switzerland to 15 now, including 3 positions for the affiliate in the UK. It is a success story that has already been independently recognized by the “Northwest Switzerland Young Entrepreneurs' Competition in 2010” and the “Open University Business School Alumni Award Committee in 2012”.

“We are delighted that SFL’s innovative spirit and commitment to its clients has been recognized by the committee of the British Swiss Business Awards” commented Shayesteh Fürst-Ladani, SFL’s managing director. “The SFL team is uniquely set to support clients thanks to our combination of regulatory, policy, scientific and legal backgrounds. We can tailor our deliverables to suit both small and large clients and yet not lose the personal approach. Our clients particularly appreciate the cross-functional approach we bring to projects so that they get answers that have been considered from different angles.”

“SFL’s involvement in the healthcare sector also extends beyond working on client-related projects,” she continued. “As a member of key European industry association, we are able to actively follow and provide input for European draft legislation and policies in both the pharmaceutical and medtech sectors.”

The British Swiss Business Awards reflect the wide range of successful ventures across the British-Swiss business community - from small start-ups and individual entrepreneurs to long-established businesses. Winning entries are selected on the basis of the company demonstrating a client-centric, socially sensitive philosophy, backed by a clear strategy and vision. Winners will be honored at the British-Swiss Business Awards gala dinner, organized by the British-Swiss Chamber of Commerce, at the Four Seasons Hotel des Bergues in Geneva on Thursday, 1st November, 2012.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: SFL Regulatory Affairs & Scientific Comm.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


SFL Selected As Finalist in the 2012 British-Swiss Business Awards

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Faiz Kermani - SFL-Services.com 
+41 61 361 9443 f.kermani[.]sfl-services.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SFL Regulatory Affairs & Scientific Comm. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From SFL Regulatory Affairs & Scientific Comm. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)